JP2017512769A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017512769A5 JP2017512769A5 JP2016556841A JP2016556841A JP2017512769A5 JP 2017512769 A5 JP2017512769 A5 JP 2017512769A5 JP 2016556841 A JP2016556841 A JP 2016556841A JP 2016556841 A JP2016556841 A JP 2016556841A JP 2017512769 A5 JP2017512769 A5 JP 2017512769A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- cyclopenta
- phenanthrene
- decahydro
- diol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims 28
- -1 —N (CH 2 ) n Chemical group 0.000 claims 21
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 8
- 125000001475 halogen functional group Chemical group 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 208000024827 Alzheimer disease Diseases 0.000 claims 5
- 108010024284 Apolipoprotein C-II Proteins 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 230000005714 functional activity Effects 0.000 claims 5
- 229940124597 therapeutic agent Drugs 0.000 claims 5
- GBAGOJGTNKBYMI-OCJHARCKSA-N (6r,8r,9s,10r,13s,14s)-6-(methoxymethyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound C([C@@]12C)CC(O)CC1[C@H](COC)C[C@@H]1[C@@H]2CC[C@]2(C)C(O)CC[C@H]21 GBAGOJGTNKBYMI-OCJHARCKSA-N 0.000 claims 4
- DFCZQECVFFVKDE-UHFFFAOYSA-N 3-phenanthryl hydrogen sulfate Chemical compound C1=CC=C2C3=CC(OS(=O)(=O)O)=CC=C3C=CC2=C1 DFCZQECVFFVKDE-UHFFFAOYSA-N 0.000 claims 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 4
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- NMPCUPPFFBXPKH-LOPRSAABSA-N (6r,8s,9s,14s,17s)-6-(methoxymethyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenanthrene-3,17-diol Chemical compound C12=CC=C(O)C=C2[C@H](COC)C[C@@H]2[C@@H]1CCC1[C@@H](O)CC[C@H]12 NMPCUPPFFBXPKH-LOPRSAABSA-N 0.000 claims 2
- 125000006711 (C2-C12) alkynyl group Chemical group 0.000 claims 2
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229930182480 glucuronide Natural products 0.000 claims 2
- 150000008134 glucuronides Chemical class 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 2
- 150000004677 hydrates Chemical class 0.000 claims 2
- 125000000468 ketone group Chemical group 0.000 claims 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims 2
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical group [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 150000002159 estradiols Chemical class 0.000 claims 1
- 230000003827 upregulation Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461955578P | 2014-03-19 | 2014-03-19 | |
| US61/955,578 | 2014-03-19 | ||
| PCT/US2015/021538 WO2015143201A2 (en) | 2014-03-19 | 2015-03-19 | 6-substituted estradiol derivatives for the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017512769A JP2017512769A (ja) | 2017-05-25 |
| JP2017512769A5 true JP2017512769A5 (cg-RX-API-DMAC7.html) | 2018-04-26 |
Family
ID=54141046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016556841A Pending JP2017512769A (ja) | 2014-03-19 | 2015-03-19 | アルツハイマー病の治療のための６−置換エストラジオール誘導体 |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102719543B1 (ko) * | 2019-06-03 | 2024-10-17 | 아이홀 코포레이션 | 히알루로난 접합체 및 이의 용도 |
| US20210024568A1 (en) * | 2019-07-23 | 2021-01-28 | Endece Llc | Methods for modulation of lipoprotein lipase and apolipoprotein c2 expression and/or activity in the treatment of peripheral and central nervous system tissue disease states |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10174070B2 (en) * | 2005-09-30 | 2019-01-08 | Endece Llc | 6-substituted estradiol derivatives and methods of use |
| WO2008100560A2 (en) * | 2007-02-14 | 2008-08-21 | University Of Southern California | Estrogen receptor modulators, associated pharmaceutical compositions and methods of use |
| WO2012129324A2 (en) * | 2011-03-21 | 2012-09-27 | Endece Llc | 6-substituted estradiol derivatives for use in remyelination of nerve axons |
-
2015
- 2015-03-19 JP JP2016556841A patent/JP2017512769A/ja active Pending
- 2015-03-19 AU AU2015231172A patent/AU2015231172A1/en not_active Abandoned
- 2015-03-19 EP EP15765290.0A patent/EP3119402A4/en not_active Withdrawn
- 2015-03-19 SG SG11201607693WA patent/SG11201607693WA/en unknown
- 2015-03-19 CN CN201580014623.7A patent/CN106255501A/zh active Pending
- 2015-03-19 US US14/663,043 patent/US20150265630A1/en not_active Abandoned
- 2015-03-19 KR KR1020167028986A patent/KR20160136363A/ko not_active Withdrawn
- 2015-03-19 MX MX2016012045A patent/MX2016012045A/es unknown
- 2015-03-19 BR BR112016021408A patent/BR112016021408A2/pt not_active IP Right Cessation
- 2015-03-19 CA CA2940536A patent/CA2940536A1/en not_active Abandoned
- 2015-03-19 WO PCT/US2015/021538 patent/WO2015143201A2/en not_active Ceased
-
2018
- 2018-02-12 AU AU2018201003A patent/AU2018201003A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013512260A5 (cg-RX-API-DMAC7.html) | ||
| ES2893166T3 (es) | Derivados de imidazoquinolina y su uso en terapia | |
| US9096640B2 (en) | 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-diene-11-methylene oxyalkylene aryl derivatives, process for preparation thereof, and use thereof for treatment of diseases | |
| US9096639B2 (en) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylene phenyl derivatives, methods for the production thereof and use thereof for treating diseases | |
| KR101864973B1 (ko) | 호흡기 세포융합 바이러스 감염의 치료에 유용한 피롤로[1,2-f][1,2,4]트리아진 | |
| WO2011066542A3 (en) | 6-substituted estradiol derivatives and methods of use | |
| JP2017512769A5 (cg-RX-API-DMAC7.html) | ||
| JP2011529071A5 (cg-RX-API-DMAC7.html) | ||
| JP2013528600A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020086616A5 (cg-RX-API-DMAC7.html) | ||
| CZ304294B6 (cs) | Léčivo a farmaceutická souprava | |
| ME02554B (me) | Ibat inhibitori za lečenje bolesti jetre | |
| JP2013519645A5 (cg-RX-API-DMAC7.html) | ||
| JP2015506348A5 (cg-RX-API-DMAC7.html) | ||
| JP2011500621A5 (cg-RX-API-DMAC7.html) | ||
| JP2010507685A5 (cg-RX-API-DMAC7.html) | ||
| JP2020514270A5 (cg-RX-API-DMAC7.html) | ||
| JP2014508807A5 (cg-RX-API-DMAC7.html) | ||
| JP2013523740A5 (cg-RX-API-DMAC7.html) | ||
| RU2006129289A (ru) | Антагонисты мускариновых ацетилхолиновых рецепторов | |
| CZ275595A3 (en) | Steroids with 17-spiromethylene lactone or lactol group, process of their preparation, their use and pharmaceutical compositions containing thereof | |
| HRP20250317T1 (hr) | SUPSTITUIRANI 3,4,12,12A‑TETRAHIDRO‑1H‑[1,4]OKSAZINO[3,4‑c]PIRIDO[2,1‑f][1,2,4]TRIAZIN‑6,8‑DION, FARMACEUTSKI PRIPRAVAK, TE POSTUPCI NJIHOVE PRIPRAVE I UPOTREBE | |
| RU2009109100A (ru) | НОВЫЕ 5,7-ДИЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ [1,3]ТИАЗОЛО[4,5-d]ПИРИМИДИН-2(3Н)-ОНА И ИХ ПРИМЕНЕНИЕ В ТЕРАПИИ | |
| WO2016102776A1 (en) | Prodrugs of 17.beta.-hsd1 -inhibitors | |
| ES2204613T3 (es) | Androgenos 7-alfa alquilo oralmente activos. |